Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Gut microbiota in COVID-19: key microbial changes, potential mechanisms and clinical applications
Fen Zhang, Raphaela Iris Lau, Qin Liu, et al.
Nature Reviews Gastroenterology & Hepatology (2022) Vol. 20, Iss. 5, pp. 323-337
Open Access | Times Cited: 185

Showing 1-25 of 185 citing articles:

A synbiotic preparation (SIM01) for post-acute COVID-19 syndrome in Hong Kong (RECOVERY): a randomised, double-blind, placebo-controlled trial
Raphaela Iris Lau, Qi Su, I.S. Lau, et al.
The Lancet Infectious Diseases (2023) Vol. 24, Iss. 3, pp. 256-265
Open Access | Times Cited: 49
Damage to endothelial barriers and its contribution to long COVID
Xiaoming Wu, Mengqi Xiang, Haijiao Jing, et al.
Angiogenesis (2023) Vol. 27, Iss. 1, pp. 5-22
Open Access | Times Cited: 45
Fungal microbiota sustains lasting immune activation of neutrophils and their progenitors in severe COVID-19
Takato Kusakabe, Woan-Yu Lin, Jin‐Gyu Cheong, et al.
Nature Immunology (2023) Vol. 24, Iss. 11, pp. 1879-1889
Open Access | Times Cited: 42
The gut microbiome associates with phenotypic manifestations of post-acute COVID-19 syndrome
Qi Su, Raphaela Iris Lau, Qin Liu, et al.
Cell Host & Microbe (2024) Vol. 32, Iss. 5, pp. 651-660.e4
Closed Access | Times Cited: 18
Mechanisms and Clinical Implications of Human Gut Microbiota-Drug Interactions in the Precision Medicine Era
Shuaiqi Wang, Dianwen Ju, Xian Zeng
Biomedicines (2024) Vol. 12, Iss. 1, pp. 194-194
Open Access | Times Cited: 15
Mucosal immune response in biology, disease prevention and treatment
Xiaoxue Zhou, Yuchen Wu, Zhipeng Zhu, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 2
Detrimental effects of COVID-19 in the brain and therapeutic options for long COVID: The role of Epstein–Barr virus and the gut–brain axis
Kenji Hashimoto
Molecular Psychiatry (2023) Vol. 28, Iss. 12, pp. 4968-4976
Open Access | Times Cited: 35
Gut microbiota composition during hospitalization is associated with 60-day mortality after severe COVID-19
Marius Trøseid, Jan Cato Holter, Kristian Holm, et al.
Critical Care (2023) Vol. 27, Iss. 1
Open Access | Times Cited: 32
Laboratory Findings and Biomarkers in Long COVID: What Do We Know So Far? Insights into Epidemiology, Pathogenesis, Therapeutic Perspectives and Challenges
Dimitrios Tsilingiris, Natalia G. Vallianou, Ιrene Karampela, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 10458-10458
Open Access | Times Cited: 31
Emerging role of the gut microbiome in post-infectious irritable bowel syndrome: A literature review
Vasile Valeriu Lupu, Cristina Mihaela Ghiciuc, Gabriela Ștefănescu, et al.
World Journal of Gastroenterology (2023) Vol. 29, Iss. 21, pp. 3241-3256
Open Access | Times Cited: 29
The relationship between gut microbiota and COVID-19 progression: new insights into immunopathogenesis and treatment
Man Wang, Yuan Zhang, Chunmei Li, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 27
Sequential multi-omics analysis identifies clinical phenotypes and predictive biomarkers for long COVID
Kaiming Wang, Mobin Khoramjoo, Karthik K. Srinivasan, et al.
Cell Reports Medicine (2023) Vol. 4, Iss. 11, pp. 101254-101254
Open Access | Times Cited: 26
T helper 17 (Th17) cell responses to the gut microbiota in human diseases
Chao‐Yue Sun, Na Yang, Zuo-Liang Zheng, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 161, pp. 114483-114483
Open Access | Times Cited: 25
Association between Gut Microbiota and SARS-CoV-2 Infection and Vaccine Immunogenicity
Ho Yu Ng, Wai K. Leung, Ka Shing Cheung
Microorganisms (2023) Vol. 11, Iss. 2, pp. 452-452
Open Access | Times Cited: 22
A systematic framework for understanding the microbiome in human health and disease: from basic principles to clinical translation
Ziqi Ma, Tao Zuo, Norbert Frey, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 12
Fucoidan from Ascophyllum nodosum and Undaria pinnatifida attenuate SARS-CoV-2 infection in vitro and in vivo by suppressing ACE2 and alleviating inflammation
Fang‐Shu Shi, Yv-Hao Xie, Yong‐Le Yang, et al.
Carbohydrate Polymers (2024) Vol. 332, pp. 121884-121884
Closed Access | Times Cited: 11
A systematic review of the association between environmental risk factors and the development of irritable bowel syndrome
Qin Xiang Ng, Clyve Yu Leon Yaow, Jia Rong Moo, et al.
Journal of Gastroenterology and Hepatology (2024) Vol. 39, Iss. 9, pp. 1780-1787
Open Access | Times Cited: 10
COVID-19 influenced gut dysbiosis, post-acute sequelae, immune regulation, and therapeutic regimens
Sterlin T. Raj, Alexander W. Bruce, Muralidharan Anbalagan, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access | Times Cited: 10
Faecalibacterium duncaniae as a novel next generation probiotic against influenza
Loïc Chollet, Séverine Heumel, Lucie Deruyter, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 9
Gut Microbiome Composition and Dynamics in Hospitalized COVID-19 Patients and Patients with Post-Acute COVID-19 Syndrome
Monta Brīvība, Laila Silamiķele, Līga Birzniece, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 1, pp. 567-567
Open Access | Times Cited: 8
Gut Microbiome Disruption Following SARS-CoV-2: A Review
Elda Righi, Ilaria Dalla Vecchia, Nina Auerbach, et al.
Microorganisms (2024) Vol. 12, Iss. 1, pp. 131-131
Open Access | Times Cited: 8
Chronic inflammation in post-acute sequelae of COVID-19 modulates gut microbiome: a review of literature on COVID-19 sequelae and gut dysbiosis
Najeeha Talat Iqbal, Hana Khan, Aqsa Khalid, et al.
Molecular Medicine (2025) Vol. 31, Iss. 1
Open Access | Times Cited: 1
Enterococci for human health: a friend or foe?
Yue Wang, Wenfeng Xu, Sirui Guo, et al.
Microbial Pathogenesis (2025) Vol. 201, pp. 107381-107381
Closed Access | Times Cited: 1
The microbiome: an integral player in immune homeostasis and inflammation in the respiratory tract
Olaf Perdijk, Rossana Azzoni, Benjamin J. Marsland
Physiological Reviews (2023) Vol. 104, Iss. 2, pp. 835-879
Closed Access | Times Cited: 20
Gastrointestinal symptoms of long COVID-19 related to the ectopic colonization of specific bacteria that move between the upper and lower alimentary tract and alterations in serum metabolites
Deyu Zhang, Siyuan Weng, Chuanchao Xia, et al.
BMC Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 18
Page 1 - Next Page

Scroll to top